1. Home
  2. GFAI vs RANI Comparison

GFAI vs RANI Comparison

Compare GFAI & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GFAI
  • RANI
  • Stock Information
  • Founded
  • GFAI 2018
  • RANI 2012
  • Country
  • GFAI Singapore
  • RANI United States
  • Employees
  • GFAI N/A
  • RANI N/A
  • Industry
  • GFAI Diversified Commercial Services
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • GFAI Consumer Discretionary
  • RANI Health Care
  • Exchange
  • GFAI Nasdaq
  • RANI Nasdaq
  • Market Cap
  • GFAI 24.6M
  • RANI 24.2M
  • IPO Year
  • GFAI N/A
  • RANI 2021
  • Fundamental
  • Price
  • GFAI $1.03
  • RANI $2.52
  • Analyst Decision
  • GFAI Strong Buy
  • RANI Strong Buy
  • Analyst Count
  • GFAI 1
  • RANI 6
  • Target Price
  • GFAI $4.50
  • RANI $8.67
  • AVG Volume (30 Days)
  • GFAI 505.7K
  • RANI 42.4M
  • Earning Date
  • GFAI 09-23-2025
  • RANI 11-13-2025
  • Dividend Yield
  • GFAI N/A
  • RANI N/A
  • EPS Growth
  • GFAI N/A
  • RANI N/A
  • EPS
  • GFAI N/A
  • RANI N/A
  • Revenue
  • GFAI $36,987,715.00
  • RANI $1,200,000.00
  • Revenue This Year
  • GFAI $5.66
  • RANI N/A
  • Revenue Next Year
  • GFAI $4.69
  • RANI N/A
  • P/E Ratio
  • GFAI N/A
  • RANI N/A
  • Revenue Growth
  • GFAI 4.38
  • RANI N/A
  • 52 Week Low
  • GFAI $0.76
  • RANI $0.39
  • 52 Week High
  • GFAI $3.88
  • RANI $3.87
  • Technical
  • Relative Strength Index (RSI)
  • GFAI 37.20
  • RANI 80.29
  • Support Level
  • GFAI $1.02
  • RANI $0.46
  • Resistance Level
  • GFAI $1.08
  • RANI $0.50
  • Average True Range (ATR)
  • GFAI 0.07
  • RANI 0.37
  • MACD
  • GFAI -0.01
  • RANI 0.26
  • Stochastic Oscillator
  • GFAI 10.95
  • RANI 60.00

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is an integrated solution provider, specializing in security solutions, and also focuses on implementing AI and robotics solutions to improve business operational efficiency and sales and marketing processes, especially for the retail and travel industry in the Asia Pacific. The company's operating business segments include Secured Logistics, AI & Robotics Solution Business, General Security Solutions, and Corporate and others. A majority of its revenue is generated from the Secured Logistics segment, which includes services like cash-in-transit, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: